Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lantigen B for prevention of recurrent respiratory tract infections in adults with possible perennial inhalant allergy
2011-003239-76Phase 4Completed
- Sponsor
- Bruschettini
- Start
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Lantigen B in Airways Infection, bacterial airway infections, upper respiratory infection (URI), pulmonary infection, sponsored by Bruschettini. Started Dec 2011; status: completed.
02
Drugs
Lantigen B
03
Conditions
Airways Infectionbacterial airway infectionsupper respiratory infection (URI)pulmonary infection
Beyond the preview
Go deeper on 2011-003239-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003239-76.